Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAs
AssigneeMessage Pharmaceuticals
InventorsTony Giordano, Michael A. Sturgess
Life of this patent
Estimating the term…
Abstract
The invention features compounds that inhibit secretion of a protein encoded by an ARE-mRNA or that modulate regulation of an ARE-mRNA. These compounds are useful for the treatment or prevention of conditions involving proteins encoded by ARE-mRNAs, such as TNFα.
Claims20
A compound having one of the following formulas:
- 50
- or a derivative or salt thereof, wherein
- R1 and R6 are independently selected from the group consisting of an alkyl and an aryl group;
- R2 and R5 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- R3 and R4 are independently selected from the group consisting of hydrogen and an alkyl group;
- X is oxygen or H2N(HN)C(H)NN—;
- and
- m is at least one;
- 51
- or a derivative or salt or salt thereof, wherein
- R1 and R6 are independently selected from the group consisting of an alkyl and an aryl group;
- R2 and R5 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- R3 and R4 are independently selected from the group consisting of hydrogen and an alkyl;
- and
- m is at least one;
- 52
- or a derivative or salt or salt thereof , wherein
- R1 and R2 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- R3 and R4 are independently selected from the group consisting of an alkyl and an aryl group;
- and
- X is oxygen or H2N(HN)C(H)NN—;
- 53
- or a derivative or salt or salt thereof, wherein
- R1 and R4 are independently selected from the group consisting of an alkyl and an aryl group;
- and
- R2 and R3 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- 54
- or a derivative or salt or salt thereof, wherein
- R1 and R5 are independently selected from the group consisting an aryl and an alkyl group;
- R2 is hydrogen, an alkyl, or aryl group;
- R3 and R4 are independently selected from the group consisting of hydrogen and an alkyl group;
- X is oxygen or H2N(HN)C(H)NN—;
- and
- m is at least one;
- 55
- or a derivative or salt or salt thereof, wherein
- R1 and R6 are independently selected from the group consisting of an alkyl and an aryl group;
- R3is hydrogen, an alkyl, or an aryl group;
- R2, R4, and R5 are independently selected from the group consisting of hydrogen and an alkyl;
- and
- m is at least one;
- or
- 56
- or a derivative or salt or salt thereof, wherein
- R1 and R2 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- R3 is an aryl group;
- and
- m is at least one.
A method for treating or preventing a condition in a subject, said method comprising administering to said subject a chemical compound in an amount sufficient to inhibit secretion of a protein encoded by an ARE-mRNA or modulate regulation of an ARE-mRNA in said subject;
- said compound having one of the following formulas:
- 57
- or a derivative or salt or salt thereof, wherein
- R1 and R6 are independently selected from the group consisting of an alkyl and an aryl group;
- R2 and R5 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- R3 and R4 are independently selected from the group consisting of hydrogen and an alkyl group;
- X is oxygen or H2N(HN)C(H)NN—;
- and
- m is at least one;
- 58
- or a derivative or salt thereof, wherein
- R1 and R6 are independently selected from the group consisting of an alkyl and an aryl group;
- R2 and R5 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- R3 and R4 are independently selected from the group consisting of hydrogen and an alkyl;
- and
- m is at least one;
- 59
- or a derivative or salt thereof, wherein
- R1 and R2 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- R3 and R4 are independently selected from the group consisting of an alkyl and an aryl group;
- and
- X is oxygen or H2N(HN)C(H)NN—;
- 60
- or a derivative or salt thereof, wherein
- R1 and R4 are independently selected from the group consisting of an alkyl or an aryl group;
- and
- R2 and R3 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- 61
- or a derivative or salt thereof, wherein
- R1 and R5 are independently selected from the group consisting an aryl or alkyl group;
- R2 is hydrogen, an alkyl, or aryl group;
- R3 and R4 are independently selected from the group consisting of hydrogen and an alkyl group;
- X is oxygen or H2N(HN)C(H)NN—;
- and
- m is at least one;
- 62
- or a derivative or salt thereof, wherein
- R1 and R6 are independently selected from the group consisting of an alkyl and an aryl group;
- R3 is hydrogen, an alkyl, and an aryl group;
- R2, R4, and R5 are independently selected from the group consisting of hydrogen and an alkyl;
- and
- m is at least one;
- or
- 63
- or a derivative or salt thereof, wherein
- R1 and R2 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- R3 is an aryl group;
- and
- m is at least one.
A method of forming a compound of interest, said method comprising reacting
- (a) a first compound having the formula:
- 64
- (b) a second compound having the formula:
- 65
- (c) a third compound having the formula:
- 66
- (d) a fourth compound having the formula:
- 67
- (e) a fifth compound having the formula:
- 68
- (f) a sixth compound having the formula:
- 69
- wherein
- R1, R3, R6, and R9 are each a protecting group;
- R2 is selected from the group consisting of hydrogen and an alkyl;
- R4 is hydrogen;
- R5, R7, R8, R10, and R11 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- X is carbon, nitrogen, oxygen, or sulfur;
- and
- m and n are at least one.
A method of forming a compound of interest, said method comprising reacting
- (a) a first compound having the formula:
- 70
- (b) a second compound having the formula:
- 71
- (c) a third compound having the formula:
- 72
- (d) a fourth compound having the formula:
- 73
- (e) a fifth compound having the formula:
- 74
- wherein
- R1 , R3, and R6 are each a protecting group;
- R2 is selected from the group consisting of hydrogen and an alkyl;
- R4 is hydrogen;
- R5, R7, R8, and R9 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- X is carbon, nitrogen, oxygen, or sulfur;
- and
- m and n are at least one.
A method of forming a compound of interest, said method comprising reacting
- (a) a first compound having the formula:
- 75
- (b) a second compound having the formula:
- 76
- wherein
- R4 is hydrogen;
- R1 , R2, R3, and R5 are independently selected from the group consisting of hydrogen, an alkyl, and an aryl group;
- R6 is an aryl group
- X is carbon or nitrogen;
- and
- m is at least one.
Dependencies are inferred from the claim text.